(3,4-Dihydroxyphenyl)-2-pyridinyl-methanone Hydrobromide is an intermediate in synthesizing Rimiterol Hydrobromide (R517500), which is a sympathomimetic amine used as a bronchodilator in the treatment of asthma. Rimiterol is a highly specific b2-adrenoceptor agonist.
